NEUCA S.A. (FRA:7HD)

Market Cap	879.64M
Revenue (ttm)	3.13B
Net Income (ttm)	36.04M
Shares Out	n/a
EPS (ttm)	7.94
PE Ratio	24.40
Forward PE	19.49
Dividend	3.76 (1.96%)
Ex-Dividend Date	Jul 15, 2025

Volume	n/a
Average Volume	1
Open	192.00
Previous Close	189.40
Day's Range	192.00 - 192.00
52-Week Range	145.40 - 205.50
Beta	n/a
RSI	61.56
Earnings Date	Nov 20, 2025

About NEUCA

NEUCA S.A. engages in the wholesale distribution of pharmaceuticals in Poland. It operates through Wholesale Distribution of Medicines, Manufacture of Pharmaceuticals, Medical Operator, Clinical Trials, and Insurance Activities segments. The company offers Rx, OTC drugs, dietary supplements, medical devices, dermocosmetics, hygiene products, personal protective equipment, as well as diagnostic and dressing materials under the Świat Zdrowia, APTEO, GENOPTIM, CERA+ Solutions, and Kic Kic brands. It also provides medical care services, including p...

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 1990
• Employees: 4,445
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 7HD

Financial Performance

In 2024, NEUCA's revenue was 12.61 billion, an increase of 6.76% compared to the previous year's 11.81 billion. Earnings were 154.24 million, an increase of 5.45%.

Financial numbers in PLN